Abstract:Besides their well-established roles in dietary lipid absorption and cholesterol homeostasis, bile acids (BA) also act as metabolically active signaling molecules. The flux of reabsorbed BA undergoing enterohepatic circulation, arriving in the liver with the co-absorbed nutrients (e.g. glucose, lipids), provides a signal that coordinates hepatic triglyceride (TG), glucose and energy homeostasis. As signaling molecules with systemic endocrine functions, BA can activate protein kinases A and C as well as mitogen-activated protein kinase pathways. Additionally, they are ligands for a G-protein-coupled BA receptor (TGR5/Gpbar-1) and activate nuclear receptors such as farnesoid X receptor (FXR; NR1H4). FXR and its downstream targets play a key role in the control of hepatic de novo lipogenesis, very-low-density lipoprotein-TG export and plasma TG turnover. BA-activated FXR and signal transduction pathways are also involved in the regulation of hepatic gluconeogenesis, glycogen synthesis and insulin sensitivity. Via TGR5, BA are able to stimulate glucagon-like peptide-1 secretion in the small intestine and energy expenditure in brown adipose tissue and skeletal muscle. Dysregulation of BA transport and impaired BA receptor signaling may contribute to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Thus, BA transport and BA-controlled nuclear receptors and signaling pathways are promising drug targets for treatment of NAFLD. As such, FXR and/or TGR5 ligands have shown promising results in animal models of NAFLD and clinical pilot studies. Despite being a poor FXR and TGR5 ligand, ursodeoxycholic acid (UDCA) improves hepatic ER stress and insulin sensitivity. Notably, norUDCA, a side chain-shortened homologue of UDCA, improves fatty liver and atherosclerosis in Western diet-fed ApoE(-/-) mice. Collectively, these findings suggest that BA and targeting their receptor/signaling pathways may represent a promising approach to treat NAFLD and closely linked disorders such as obesity, diabetes, dyslipidemia and arteriosclerosis.

Correction: Roles of Bile Acids Signaling in Neuromodulation under Physiological and Pathological Conditions

Roles of bile acids signaling in neuromodulation under physiological and pathological conditions

Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis

The Biosynthesis, Signaling, and Neurological Functions of Bile Acids

Bile Acid Signaling in the Regulation of Whole Body Metabolic and Immunological Homeostasis.

The clinical and mechanistic roles of bile acids in depression, Alzheimer's disease, and stroke

Molecular Functions and Therapeutic Implications

Bile Acids: A Communication Channel in the Gut-Brain Axis

The role of bile acids in regulating glucose and lipid metabolism.

Therapeutic Roles of Bile Acid Signaling in Chronic Liver Diseases

Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism

Critical Roles of Bile Acids in Regulating Intestinal Mucosal Immune Responses

Bile Acid Signaling in Neurodegenerative and Neurological Disorders

Bile acids, bioactive signalling molecules in interoceptive gut-to-brain communication

Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart

Biological Functions and Pharmacological Behaviors of Bile Acids in Metabolic Diseases.

Overview of Bile Acid Signaling in the Cardiovascular System

Bile-ology: from Bench to Bedside.

Bile acid metabolism in health and ageing-related diseases

The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications